Developing and Evaluating an Indoor Air Pollution Intervention Among Cardiovascular Patients: the AIRWISE Study

Last updated: June 3, 2025
Sponsor: University of Montana
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Coronary Artery Disease

Myocardial Ischemia

Hypercholesterolemia

Treatment

AIRWISE

Clinical Study ID

NCT06384625
361378
  • Ages > 55
  • All Genders

Study Summary

This pilot study (n=20) is a prospective evaluation of the implementation of an indoor air pollution intervention among adults 55 years of age or older. The intervention, called Air Improvement and Real-time Monitoring for Wellness through Interactive Strategies and Education (AIRWISE), is focused on improving indoor air quality through air filtration, education, and behavioral recommendations. All participants will receive the AIRWISE intervention with the objective of evaluating acceptance and use of the individual intervention components. This implementation study will inform the submission of a larger NIH proposal for a randomized trial. The central study hypothesis is that an intervention program with educational strategies and visual behavioral cues will increase knowledge and awareness of air pollution exposures among the participants and lead to improved intervention compliance.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adult of at least 55 years of age

  • One primary residence (5+ days per week)

  • Own a computer or electronic device (tablet or phone with web browser), and reliableinternet connection or cell phone service (required to submit study surveys)

  • Access to a working email address (required to submit study surveys)

  • Electricity in the home (required to power the study equipment)

Exclusion

Exclusion Criteria:

  • Current smoking of any kind (tobacco, cannabis, vape pens, cigars, etc.) or livingin a household with someone who currently smokes

  • Current use of stand-alone home high efficiency purified air (HEPA) filtration orPAC unit in the home

  • Intention to move in the next 6 months

  • Another person in the household is enrolled in this study (one person per householdcan enroll)

  • Having any health condition that prevents the participants from having bloodpressure measured using an upper-arm cuff: lymphedema, paresis or paralysis,arterial or venous lines/catheters, dialysis shunt, recent surgical wounds, ormastectomy

Study Design

Total Participants: 20
Treatment Group(s): 1
Primary Treatment: AIRWISE
Phase:
Study Start date:
July 24, 2024
Estimated Completion Date:
December 31, 2025

Connect with a study center

  • University of Montana

    Missoula, Montana 59812
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.